Categories Analysis, Consumer

Campbell Soup (CPB): Main takeaways from the Q1 2024 earnings report

Adjusted EPS is expected to range between $3.09-3.15 in FY2024

Shares of Campbell Soup Company (NYSE: CPB) gained over 7% on Wednesday, following the announcement of the company’s first quarter 2024 earnings results. The stock has dropped 23% year-to-date. The company also reaffirmed its guidance for the full year of 2024. Here are the main takeaways from the report:

Profits beat, sales in-line

Campbell Soup’s net sales for Q1 2024 decreased 2% year-over-year to $2.52 billion but were in line with estimates. Organic sales were down 1%. GAAP EPS fell 21% YoY to $0.78. Adjusted EPS of $0.91 dropped 11% versus last year but managed to surpass projections.

Segment performance

In Q1, net sales in the Meals & Beverages segment decreased 4% on a reported basis and 3% on an organic basis, due to declines in US retail products, mainly soup and beverages. This was partly offset by an increase in foodservice. Weakness in the condensed and ready-to-serve categories, partly offset by growth in broth, led to a 5% drop in sales for US soup. Volume/mix within the segment declined 6%, partly offset by net price realization of 2%.

In the Snacks segment, net sales decreased 1%. Excluding impacts from the Emerald nuts business divestiture, organic sales grew 1%. This growth was driven by a 5% increase in sales of its 8 power brands. The segment benefited from gains in cookies and crackers, particularly Lance sandwich crackers and Goldfish crackers. Net price realization of 5% was partly offset by volume/mix declines of 4%.

Outlook

Campbell reaffirmed its guidance for the full year of 2024. Net sales growth is expected to range between down 0.5% to up 1.5% YoY. Organic sales are expected to grow 0-2%. The top line guidance reflects volume declines in 1H24 with sequential improvement anticipated to result in positive volume trends in the latter half of the year. Net sales growth for the year is also expected to reflect lower contribution from pricing.

The company expects a modest progress in earnings and margin in FY2024, weighted to the second half, reflecting a moderation in inflation and productivity improvements. Adjusted EPS is expected to range between $3.09-3.15, representing a growth of 3-5% from the previous year.

Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top